Medibank Private Ltd shares fall: Should you buy more?

Is it time to give up on the Medibank Private Ltd (ASX:MPL) growth story?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in Medibank Private Ltd (ASX: MPL) fell to $2.15 on Thursday afternoon, only 2% from its lowest level for the year and just 4% above the all-time low of $2.08 hit shortly after listing in 2014.

To make matters worse, Medibank's shares have underperformed the market by nearly 17% in 2015! Medibank's shares have plunged 10.8%, while the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) is up 5.6%.

What's Happened?

One may be tempted to conclude that the fall is to do with some negative sentiment over the health insurance sector, however this doesn't appear to be the case, with close rival NIB Holdings Limited (ASX: NHF) up 20% in this calendar year alone!

I think there are three reasons why investors have started to question the Medibank investment theory:

  1. It's going to be harder for Medibank to grow in the future. The cost of private health cover is becoming prohibitively expensive for the average consumer. Health insurance premium inflation has rocketed ahead of general inflation over the last 10 years, with the average premium for comprehensive cover well over $1,000 per year per person. New, low-cost entrants are also stealing market share from Australia's largest insurer.
  2. It's not the dividend feast many had expected. Medibank's first year yield of around 4% is equalled or beaten by other large companies with decent growth prospects like Telstra Corporation Ltd (ASX: TLS), QBE Insurance Group Ltd (ASX: QBE), Suncorp Group Ltd (ASX: SUN) and Commonwealth Bank of Australia (ASX: CBA).
  3. Key personnel don't appear to be performing. Some analysts have picked up on the fact that there has been a significant management reshuffle. The IPO prospectus declared that the company would have 'a highly experienced board and management team with significant business and industry experience'. The Chief Customer Officer has left after disappointing customer growth (or lack of) with other changes in the works.

The poor performance of Medibank raises questions for the outlook of the stock over the next 12 months. Unless the group's management can grow margins in this half, I expect we will see the share price fall so that it more closely aligns with low-growth, moderate income stocks.

Medibank needs to find a way to either significantly boost its dividend or significantly boost its growth prospects so that investors can decide what they're investing in.

Motley Fool contributor Andrew Mudie owns shares of QBE Insurance Group Ltd. You can find Andrew on Twitter @andrewmudie. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »